Prevention and Early Detection of Ulcer Recurrence in Patients With Type II Diabetes Mellitus
A Randomized Clinical Trial Study on the Prevention Strategy and Early Detection of Ulcer Recurrence in Patients With Type II Diabetes Mellitus Using the Risk of Recurrence Ulcer Tool
1 other identifier
interventional
60
1 country
1
Brief Summary
The goal of this clinical trial is to to evaluate the effectiveness of prevention strategies of recurrence in DFU's. It will also to detect the risk level of recurrence. The main question it aims to answer are:
- Does intervention of prevention strategies effective to prevent the recurrence of DFU's?
- How the risk level of the recurrence on DFU's patients?
- How the impact of quality of life on DFU's patients? Researchers will compare intervention groups (receiving education covered various aspects, including they received guidance on foot examination, foot care, dietary habits, physical exercise, and stress management), and control groups (received standards follow-up care provided by healthcare providers, including pamphlets outlining care for DM patients based on the five pillars, including DM management, medication adherence, dietary practices, physical exercise routines, and foot care). Participants will:
- For intervention group will be educated every month
- Data for both intervention and control groups were collected monthly until three months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedFirst Submitted
Initial submission to the registry
May 18, 2024
CompletedFirst Posted
Study publicly available on registry
May 30, 2024
CompletedMay 31, 2024
May 1, 2024
6 months
May 18, 2024
May 29, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
The degree of risk of recurrence
The risk level recurrence ulcer tool, INDIFURUTO (Indonesian Diabetic Foot Ulcer Recurrence Assessment Tool), was used to assess the risk level. Subjects were categorized as high risk if they scored less than or equal to 22 points, medium risk if they scored between 23 and 45, and low risk if they scored more than or equal to 46.
up to three months
Efficacy of prevention strategies
Prevention stratagies is evaluated using INDIFURUTO tool (history of amputation, smoking, serum glucose levels, ankle-brachial index, monofilament test results, and differences in foot skin temperature). Good=INDIFURUTO total score increase than baseline and Poor=INDIFURUTO total score decrease than baseline
up to three months
Secondary Outcomes (2)
Quality of life of DFU's
up to three months
Health status of DFU's
up to three months
Study Arms (2)
Prevention Strategies
EXPERIMENTALGroups received the prevention strategies to prevent the recurrence of DFU's
Standard Strategies
OTHERGroups received the standard strategies to prevent the recurrence of DFU's
Interventions
Data collection sessions lasted approximately 1 to 1.50 hours, with education and foot care provided once a month. Subsequently, patients underwent monthly follow-ups for three months, during which they received guidance on foot examination, foot care, dietary habits, physical exercise, and stress management.
Group were educated about DM management, medication adherence, dietary practices, physical exercise routines, and foot care through pamphlets
Eligibility Criteria
You may qualify if:
- Participants have a history of diabetic foot ulcers.
- signed an informed consent
You may not qualify if:
- Declined to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Haryanto Haryanto
Pontianak, West Kalimantan, 78164, Indonesia
Related Publications (1)
Haryanto H, Sari Y, Panjaitan E, Juminar J, Armstrong D. A Randomized Clinical Trial Study on the Prevention Strategy and Early Detection of Ulcer Recurrence in Patients with Type 2 Diabetes Mellitus Using the Risk of Recurrence Ulcer Tool. Int J Low Extrem Wounds. 2025 Sep;24(3):655-663. doi: 10.1177/15347346241283160. Epub 2024 Oct 21.
PMID: 39434549DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Haryanto Haryanto
ITEKES Muhammadiyah Kalimantan Barat
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- The investigators known the groups.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 18, 2024
First Posted
May 30, 2024
Study Start
January 1, 2023
Primary Completion
June 30, 2023
Study Completion
June 30, 2023
Last Updated
May 31, 2024
Record last verified: 2024-05